Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vifa3g02393 | ATGGCACTCTCGCGCCTTCGCCACCCTCTCATCTCTCATTCCCTTCGTATCCTCTCTTCCTCCACCAGATCCATCTCTCGAACCCCCAATTCAAGGATTTATTCTGTTGGTGGTAATGGGAATCTAAGGCCTACATCTTGGTCTGGGATTACTGGAGTTTGTGATAGACCCTTGAAGTCTAAGTGGATTGATGTCAAATTCTTCTCGTCTTCAGATTTTCCACATGAAGTCCTTGGTATGCCAGCGTTATCTCCTACAATGACCCAAGGTAATATTGCAAAGTGGAGGAAAAAAGAAGGGGATAAGATAGCAGTGGGTGATATACTATGTGAAATTGAAACTGACAAAGCTACACTTGAATTTGAAAGTCTTGAAGAAGGATTTCTGGCTAAGATATTGGTACCTGATGGTTCAAAGGATGTGCCAGTTGGACAACCTATTGCAATAACAGTTGAGGAGGAAAGCAACATTCAAAATGTCTCAGCTTCTGTGGAGGGTGAGAGCAAGGTTGAAGAGAAGAGACCAACAAATCAGGATGTTGCGGATGAGCAAAGTAAAACAGAATCAACTTCTACAATTGATACATCAGATCTTCCACCTCATGAAATTCTCGGAATGCCTGCTTTGTCCCCAACAATGAACCAAGGAAACATTGCTAAGTGGAATAAAAAAGAAGGAGACAAGATTGAAGTGGGTGACATATTATGCGAGATAGAGACAGACAAAGCTACTCTTGAATATGAAAGTCTTGAAGAGGGGTACCTAGCTAAGATAGTTGCACCAGAAGGTACAAAAGAAGTGGCAGTCGGACAGCCTATTGCAATAACAGTTGAAGATGCGGGTGATATTGAAGCTGTAAAGAATTCTTTTAGCAGCAGCTCAATAAACCAAAAGGAGAAGGCCCCCCAACCCGGCCCTAAAAGTGAGGTCAAAACTTCCAAAAACAATACCGCACGAATCAGTCCAGCTGCGAAGTTGCTAATTACGGAATATGGATTGGATGCATCAACGTTGAAAGCAACTGGTCCTCATAGCACCCTACTGAAAAGCGATGTTCTTTCTGCAATTAAATCAGCCAAATTGTCTCCAAAACCTGCTTCATCTAAAGCAAAGGCACCATCATCTCAAAGTCATCAAGCTGCGGCTTCACAAGATTCAAAGACTGACTTAAAGCAGTCAGATGCTTATGAAGATTTTCCTAATAGTCAAATTCGCAAGGTGATTGCCAAGAGATTATTGGAATCTAAACTAAATACACCACACTTATATTTATCATCAGATGTTAAACTGGACCCTCTTCTTTCCCTTAGAAAGGATCTTATAGAGCAGTATGACGTAAAAGTTTCAGTGAATGACATTATTATCAAAGTTGTAGCGGCTGCTCTAAAAAATGTACCAGAAGCAAATGCATACTGGAGTGAAGAGAAGGGTGAAGTCATCTTATGCGATTCTGTTGACATATCAATAGCAGTTGCCACTGAAAAGGGCTTGATGACGCCAATATTAAAAAATGCCGATCATAAGACAATATCCGCCATCTCTTCTGAGGTCAAGGAACTGGCTGCAAAAGCACGTGCAGGGAAGTTGAAGCCTCAAGAGTTCCAAGGAGGTACTTTTAGCATTTCAAACTTAGGAATGTATCCCGTGGATAAATTCTGTGCAATTATAAACCCTCCACAGGCTTGCATTCTTGCTGTAGGAAGAGGCAACAAAGTTGTGGAACCAGTAATTGATGCTGATGGAATCGAGAAGCCATCAGTTGCCACTAAGTTGAACTTAACATTATCTGCGGATCATCGCGTCTTTGATGGCAAAGTTGGAGGTGCATTTCTCTCTGCTTTGAAGTCAAACTTCAGTGATATAAAACGGCTTCTTTTATAA | 1881 | 0.4147 | MALSRLRHPLISHSLRILSSSTRSISRTPNSRIYSVGGNGNLRPTSWSGITGVCDRPLKSKWIDVKFFSSSDFPHEVLGMPALSPTMTQGNIAKWRKKEGDKIAVGDILCEIETDKATLEFESLEEGFLAKILVPDGSKDVPVGQPIAITVEEESNIQNVSASVEGESKVEEKRPTNQDVADEQSKTESTSTIDTSDLPPHEILGMPALSPTMNQGNIAKWNKKEGDKIEVGDILCEIETDKATLEYESLEEGYLAKIVAPEGTKEVAVGQPIAITVEDAGDIEAVKNSFSSSSINQKEKAPQPGPKSEVKTSKNNTARISPAAKLLITEYGLDASTLKATGPHSTLLKSDVLSAIKSAKLSPKPASSKAKAPSSQSHQAAASQDSKTDLKQSDAYEDFPNSQIRKVIAKRLLESKLNTPHLYLSSDVKLDPLLSLRKDLIEQYDVKVSVNDIIIKVVAAALKNVPEANAYWSEEKGEVILCDSVDISIAVATEKGLMTPILKNADHKTISAISSEVKELAAKARAGKLKPQEFQGGTFSISNLGMYPVDKFCAIINPPQACILAVGRGNKVVEPVIDADGIEKPSVATKLNLTLSADHRVFDGKVGGAFLSALKSNFSDIKRLLL | 626 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vifa3g02393 | 626 | ProSiteProfiles | Biotinyl/lipoyl domain profile. | 75 | 151 | IPR000089 | - | |
Vifa3g02393 | 626 | FunFam | Acetyltransferase component of pyruvate dehydrogenase complex | 197 | 301 | - | - | |
Vifa3g02393 | 626 | FunFam | Acetyltransferase component of pyruvate dehydrogenase complex | 71 | 175 | - | - | |
Vifa3g02393 | 626 | FunFam | Acetyltransferase component of pyruvate dehydrogenase complex | 380 | 624 | - | - | |
Vifa3g02393 | 626 | Gene3D | - | 319 | 360 | IPR036625 | GO:0016746 | |
Vifa3g02393 | 626 | ProSiteProfiles | Peripheral subunit-binding (PSBD) domain profile. | 319 | 356 | IPR004167 | GO:0016746 | |
Vifa3g02393 | 626 | ProSiteProfiles | Biotinyl/lipoyl domain profile. | 201 | 277 | IPR000089 | - | |
Vifa3g02393 | 626 | Pfam | e3 binding domain | 319 | 353 | IPR004167 | GO:0016746 | |
Vifa3g02393 | 626 | MobiDBLite | consensus disorder prediction | 158 | 200 | - | - | |
Vifa3g02393 | 626 | Pfam | 2-oxoacid dehydrogenases acyltransferase (catalytic domain) | 396 | 625 | IPR001078 | GO:0016746 | |
Vifa3g02393 | 626 | NCBIfam | pyruvate dehydrogenase complex dihydrolipoamide acetyltransferase | 204 | 618 | IPR006257 | GO:0004742|GO:0006090|GO:0045254 | |
Vifa3g02393 | 626 | SUPERFAMILY | Peripheral subunit-binding domain of 2-oxo acid dehydrogenase complex | 312 | 357 | IPR036625 | GO:0016746 | |
Vifa3g02393 | 626 | PANTHER | DIHYDROLIPOAMIDE ACETYL/SUCCINYL-TRANSFERASE-RELATED | 195 | 626 | IPR045257 | GO:0006086|GO:0045254 | |
Vifa3g02393 | 626 | MobiDBLite | consensus disorder prediction | 368 | 395 | - | - | |
Vifa3g02393 | 626 | Gene3D | - | 380 | 626 | IPR023213 | - | |
Vifa3g02393 | 626 | CDD | lipoyl_domain | 206 | 275 | - | - | |
Vifa3g02393 | 626 | MobiDBLite | consensus disorder prediction | 288 | 316 | - | - | |
Vifa3g02393 | 626 | SUPERFAMILY | Single hybrid motif | 203 | 292 | IPR011053 | - | |
Vifa3g02393 | 626 | SUPERFAMILY | CoA-dependent acyltransferases | 390 | 626 | - | - | |
Vifa3g02393 | 626 | MobiDBLite | consensus disorder prediction | 363 | 395 | - | - | |
Vifa3g02393 | 626 | SUPERFAMILY | Single hybrid motif | 78 | 166 | IPR011053 | - | |
Vifa3g02393 | 626 | MobiDBLite | consensus disorder prediction | 166 | 181 | - | - | |
Vifa3g02393 | 626 | ProSitePatterns | 2-oxo acid dehydrogenases acyltransferase component lipoyl binding site. | 100 | 129 | IPR003016 | - | |
Vifa3g02393 | 626 | MobiDBLite | consensus disorder prediction | 182 | 197 | - | - | |
Vifa3g02393 | 626 | Pfam | Biotin-requiring enzyme | 78 | 149 | IPR000089 | - | |
Vifa3g02393 | 626 | Pfam | Biotin-requiring enzyme | 204 | 275 | IPR000089 | - | |
Vifa3g02393 | 626 | Gene3D | - | 70 | 175 | - | - | |
Vifa3g02393 | 626 | Gene3D | - | 197 | 302 | - | - | |
Vifa3g02393 | 626 | CDD | lipoyl_domain | 80 | 149 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vifa3g02393 | Vifa-Chr3 | 611455430 | 611467355 | Tandem |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vifa3g02393 | 195 | 626 | Acyl Lipid Metabolism Gene Families | AT3G13930 | 42.763 | 2.47e-109 | 338 |
Select | Gene_1 | Chr_1 | Start_1 | End_1 | Gene_2 | Chr_2 | Start_2 | End_2 | Event_name |
---|---|---|---|---|---|---|---|---|---|
Vifa3g02393 | 3 | 611455430 | 611467355 | Vifa3g02393 | 3 | 611455430 | 611467355 | ECH |